Improved productivity and speed with robust processes
The market in biologics drugs is growing at an unprecedented pace, bringing with it a raft of new opportunities. In order to gain a competitive edge, drug developers need access to efficient expression systems with the capacity to rapidly increase production as needs develop. However, it can be a challenge to commercialize microbial processes.
Our XS Technologies® provide an extensive microbial expression toolbox to help you overcome these challenges and meet your needs. With access to our highly productive and scalable platforms, you can develop high-yielding processes for a wide variety of molecules. Our technical experts can help you to optimize your strategy by balancing risks against opportunities, while ensuring your processes meet regulatory requirements.
The versatile XS Technologies® platform includes Pichia pastoris and Escherichia coli expression systems. Depending on your needs, you can access our technologies via our services or use our XS Technologies® microbial platform in your own laboratory under license. We work closely with our customers to continually improve our systems to ensure our platforms address your evolving needs.